Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
Sarah Bouchereau, L. Chaplain, Magali Fort, Alain Beauchet, T. Sidibé, M. Chapalain, Leire González‐Lara, Christine Longvert, Astrid Blom, Philippe Saïag, Elisa Funck‐Brentano
Topics & Concepts
DacarbazineMedicineMelanomaInternal medicineOncologyChemotherapyClinical endpointAdverse effectSurgeryCancer researchClinical trialCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways